IL24 and head and neck squamous cell carcinoma: A study of Bifidobacterium as a carrier of the IL24 mRNA to treat HNSCC in mice showed that the recombinant strain Bifidobacterium breve-IL24 had a stronger ability to inhibit tumor growth and induce tumor cell apoptosis [19].